Literature DB >> 10472163

Factor analysis of the psychosocial items of the EORTC QLQ-C30 in metastatic breast cancer patients participating in a psychosocial intervention study.

S A McLachlan1, G M Devins, P J Goodwin.   

Abstract

The underlying factor structure of a subset of 12 items, which comprise the psychosocial subscales of the EORTC QLQ-C30 was explored in a group of women, all with metastatic breast cancer who were participating in a psychosocial intervention study. Two main factors were identified in this exploratory factor analysis, representing "emotional distress" and "functional ability" dimensions. A preliminary assessment of the external validity of the two factor structure was undertaken. The results support the validity of a summative "emotional distress" and "functional ability" score in this sample of patients. The "functional ability" score discriminated well for subgroups defined by clinical status indicators (e.g., performance status, pain, chemotherapy treatment, fatigue). The "emotional distress" subscale discriminated with respect to suffering, fatigue and sleep disturbance. Both subscales converged with related concepts measured by independent instruments, providing support for convergent validity. Summative index scores may be advantageous for application in particular research situations; applying quality adjustments in health policy analyses; for screening purposes; to monitor populations and make comparisons across broad groups and as stratification variables in clinical trials. Further research to confirm the 2 factor structure is required in other samples before the interpretation can be accepted with confidence.

Entities:  

Mesh:

Year:  1999        PMID: 10472163     DOI: 10.1023/a:1008939818096

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  11 in total

1.  Indexes and boundaries for "quantitative significance" in statistical decisions.

Authors:  B Burnand; W N Kernan; A R Feinstein
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Randomized trial of group psychosocial support in metastatic breast cancer: the BEST study. Breast-Expressive Supportive Therapy study.

Authors:  P J Goodwin; M Leszcz; J Koopmans; A Arnold; R Doll; H Chochinov; M Navarro; K Butler; K I Pritchard
Journal:  Cancer Treat Rev       Date:  1996-01       Impact factor: 12.111

4.  Development of a questionnaire measure of adjustment to cancer: the MAC scale.

Authors:  M Watson; S Greer; J Young; Q Inayat; C Burgess; B Robertson
Journal:  Psychol Med       Date:  1988-02       Impact factor: 7.723

5.  Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients.

Authors:  S A McLachlan; G M Devins; P J Goodwin
Journal:  Eur J Cancer       Date:  1998-03       Impact factor: 9.162

6.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

7.  Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group.

Authors:  A Coates; V Gebski; D Signorini; P Murray; D McNeil; M Byrne; J F Forbes
Journal:  J Clin Oncol       Date:  1992-12       Impact factor: 44.544

8.  Pain in metastatic breast cancer.

Authors:  D Spiegel; J R Bloom
Journal:  Cancer       Date:  1983-07-15       Impact factor: 6.860

9.  Impact of Event Scale: a measure of subjective stress.

Authors:  M Horowitz; N Wilner; W Alvarez
Journal:  Psychosom Med       Date:  1979-05       Impact factor: 4.312

10.  Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses.

Authors:  G I Ringdal; K Ringdal
Journal:  Qual Life Res       Date:  1993-04       Impact factor: 4.147

View more
  10 in total

Review 1.  Multidimensional scaling as a tool for analysing quality of life data.

Authors:  G Kemmler; B Holzner; M Kopp; M Dünser; R Greil; E Hahn; B Sperner-Unterweger
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

2.  Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer.

Authors:  Nancy K Janz; Mahasin Mujahid; Paula M Lantz; Angela Fagerlin; Barbara Salem; Monica Morrow; Dennis Deapen; Steven J Katz
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

3.  Multidimensional constructs of the EORTC Quality of Life Questionnaire (QLQ-c30) in Korean cancer patients with heterogeneous diagnoses.

Authors:  Eun-Hyun Lee; Mison Chun; Hee-Jung Wang; Ho Yeong Lim; Jin-Hyuk Choi
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

4.  A feasibility study of psychosocial group intervention for breast cancer patients with first recurrence.

Authors:  Masami Chujo; Ichiro Mikami; Shigemitsu Takashima; Toshiaki Saeki; Shozo Ohsumi; Kenjiro Aogi; Hitoshi Okamura
Journal:  Support Care Cancer       Date:  2004-12-03       Impact factor: 3.603

5.  Quality of life of patients with oesophageal cancer in Taiwan: validation and application of the Taiwan Chinese (Mandarin) version of the EORTC QLQ-OES18: a brief communication.

Authors:  Wei-Chu Chie; Chia-Jih Tsai; Chieh Chiang; Yung-Chie Lee
Journal:  Qual Life Res       Date:  2010-05-22       Impact factor: 4.147

Review 6.  Psychological Factors and Characteristics of Recurrent Breast Cancer Patients with or without Psychosocial Group Therapy Intervention.

Authors:  Masami Chujo; Junzo Kigawa; Hitoshi Okamura
Journal:  Yonago Acta Med       Date:  2011-12-01       Impact factor: 1.641

7.  Comparing higher order models for the EORTC QLQ-C30.

Authors:  Chad M Gundy; Peter M Fayers; Mogens Groenvold; Morten Aa Petersen; Neil W Scott; Mirjam A G Sprangers; Galina Velikova; Neil K Aaronson
Journal:  Qual Life Res       Date:  2011-12-21       Impact factor: 4.147

8.  Evaluating the relationship between pain presentation and health-related quality of life in outpatients with metastatic or recurrent neoplastic disease.

Authors:  J E Owen; J C Klapow; L Casebeer
Journal:  Qual Life Res       Date:  2000       Impact factor: 3.440

9.  Minimal important differences of EORTC QLQ-C30 for metastatic breast cancer patients: Results from a randomized clinical trial.

Authors:  Takuya Kawahara; Naruto Taira; Takeru Shiroiwa; Yasuhiro Hagiwara; Takashi Fukuda; Yukari Uemura; Hirofumi Mukai
Journal:  Qual Life Res       Date:  2022-01-04       Impact factor: 3.440

10.  Item response theory and factor analysis as a mean to characterize occurrence of response shift in a longitudinal quality of life study in breast cancer patients.

Authors:  Amélie Anota; Caroline Bascoul-Mollevi; Thierry Conroy; Francis Guillemin; Michel Velten; Damien Jolly; Mariette Mercier; Sylvain Causeret; Jean Cuisenier; Olivier Graesslin; Zeinab Hamidou; Franck Bonnetain
Journal:  Health Qual Life Outcomes       Date:  2014-03-08       Impact factor: 3.186

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.